CNMD - CONMED - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CNMD is currently covered by 8 analysts with an average price target of $66.4. This is a potential upside of $9.65 (17%) from yesterday's end of day stock price of $56.75.

CONMED's activity chart (see below) currently has 132 price targets and 115 ratings on display. The stock rating distribution of CNMD is 77.78% BUY and 22.22% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.61% with an average time for these price targets to be met of 149.75 days.

Highest price target for CNMD is $80, Lowest price target is $55, average price target is $85.88.

Most recent stock forecast was given by MIKE MATSON from NEEDHAM on 01-May-2025. First documented stock forecast 16-Jan-2015.

Currently out of the existing stock ratings of CNMD, 28 are a BUY (77.78%), 8 are a HOLD (22.22%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$61

$4.25 (7.49%)

$91

30 days ago
(01-May-2025)

21/37 (56.76%)

$3.81 (6.66%)

236

Hold

$57

$0.25 (0.44%)

$70

30 days ago
(01-May-2025)

3/4 (75%)

$-0.19 (-0.33%)

22

Buy

$55

$-1.75 (-3.08%)

$75

1 months 3 days ago
(28-Apr-2025)

13/18 (72.22%)

$4.16 (8.18%)

144

Hold

$70

$13.25 (23.35%)

$75

3 months 25 days ago
(06-Feb-2025)

3/7 (42.86%)

$2.64 (3.92%)

190

Buy

$80

$23.25 (40.97%)

$95

9 months 30 days ago
(01-Aug-2024)

15/21 (71.43%)

$15.02 (23.11%)

221

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CNMD (CONMED) average time for price targets to be met?

On average it took 149.75 days on average for the stock forecasts to be realized with a an average price target met ratio 65.61

Which analyst has the current highest performing score on CNMD (CONMED) with a proven track record?

MATT O'BRIEN

Which analyst has the most public recommendations on CNMD (CONMED)?

Matt O'brien works at PIPER SANDLER and has 5 price targets and 7 ratings on CNMD

Which analyst is the currently most bullish on CNMD (CONMED)?

Matthew Mishan with highest potential upside - $84.25

Which analyst is the currently most reserved on CNMD (CONMED)?

Matthew Taylor with lowest potential downside - -$15.85

CONMED in the News

Impressive Earnings May Not Tell The Whole Story For CONMED (NYSE:CNMD)

CONMED Corporation’s (NYSE:CNMD) stock was strong after they recently reported robust earnings. However, our analysis suggests that shareholders may be missing some factors that indicate the earnings result was not as good as it looked. Our free stock report includes 3 warning signs investors should be aware of before investing in CONMED. Read for free...

Why Conmed (CNMD) is a Top Value Stock for the Long-Term

It doesn’t matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?